Skip to main content

Society of Classical Studies 154th Annual Meeting

JANUARY 5-8, 2023

NEW ORLEANS

Call for Papers for Panel Sponsored by the Society for Ancient Medicine

“Addiction, Dependency, and Habit”

Organized by Colin Webster (UC Davis) and Aileen Das (Michigan)

The opioid crisis has been devastating American families for almost two decades now, but despite its incredible human toll, it has barely made a ripple in academic debates, even as we enter another revolution in the use of psychotropic drugs to treat issues of mental health. We live in the conceptual shadow of moralizing prohibitions, the war on drugs, the medicalization of substance abuse, and the consequences of all these approaches. This panel seeks to explore the discourses around addictions, habits, and dependencies in antiquity, attempting to analyze these issues without the familiar frames of modern psychology and modern biomedicine. How were such issues conceptualized in antiquity? Without the categories of “psychoactive” or “psychotropic” substances, what counts as a problematic substance dependency? The Lotus-eaters of the Odyssey (Od. 9.82–104) stand as an early warning against pharmacologically induced bliss. Yet, ancient physicians frequently prescribed drugs that are high-risk for habit-formation, most notably opium and alcohol. Marcus Aurelius reportedly consumed the opium-containing drug theriac every day, and this “habit” [ethos] both created a potential addiction and allowed him to endure the hardships of military campaign (Gal. De antidotis 14.4K; cf. Diod. Sic. 71.6.3–4). Mithridates, in order to keep himself immune to poison, consumed toxic substances every day so that, as Pliny says, “he might render them harmless through habit itself [consuetudine ipse]” (Pl. NH 24.3.6; cf. Gal. De antidotis 14.4K). What does it mean when medical treatments produce dependencies or create harms? What are the dangers presented by long-term therapeutic interventions? How can we think about these issues using disability and chronic illness as frames, where the boundary between addictions and life-improving treatments is even less clear? Moreover, regimen-based medical approaches enforce near-constant attention to health in a way that itself flirts with the pathological. Eating-for-health can easily slide into a compulsive eating disorder. How do philosophical and medical notions of habit, dependency and immoderation interact? Is “moderation” the only morally-tinged principle guiding medical consumption patterns? Beyond philosophy, are there literary or mythic reflections on the dangers or benefits of pharmacological or medical dependencies? How do intraregional and intracultural drug trades shape attitudes toward particular substances? How do religious rituals involving pharmacological and therapeutic substances structure their use more broadly, either mitigating or promoting dependency? How did the prevalence of wine in Greek medicine affect its reception within Islamic tradition? Proposed papers are welcome to address these issues or any other related topics, including, but not limited to questions of chronic illness, pain, mortality, harm-reduction, risk-assessment, mental illness, gender, economics, and trade, whether in Greek, Roman, or other pre-modern contexts.

Please send abstracts that follow the guidelines for individual abstracts (see the SCS Guidelines for Authors of Abstracts) by email to Colin Webster (UC Davis) at cwebster@ucdavis.edu by March, 11, 2022. Ensure that the abstracts are anonymous. The organizers will review all submissions anonymously, and their decision will be communicated to the authors of abstracts by March 28, 2022.